• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

中国药物评价 ›› 2024, Vol. 41 ›› Issue (5): 346-348.

• 医疗器械审评科学 • 上一篇    下一篇

中国与欧盟医疗器械风险管理要求对比及分析

孙克英, 金若男   

  1. 国家药品监督管理局医疗器械技术审评中心, 北京 100081
  • 收稿日期:2024-06-04 修回日期:2024-09-02 出版日期:2024-10-28 发布日期:2024-10-28

Comparison and Analysis of Medical Device Risk Management Requirements Between China and EU

  1. Center For Medical Device Evaluation,National Medical Products Administration, Beijing 100081, China
  • Received:2024-06-04 Revised:2024-09-02 Online:2024-10-28 Published:2024-10-28

摘要: 风险管理是贯穿于医疗器械全生命周期的活动,对保证医疗器械的安全具有重要的作用。本文通过对比中国和欧盟医疗器械注册申报资料中风险管理的要求,发现两者的异同点,为医疗器械技术审评工作提供参考。

关键词: font-size:medium, "> , 医疗器械; 注册; 风险管理

Abstract: Risk management is an activity throughout the whole life cycle of medical devices,which plays an important role for assuring the safety of medical devices. By comparing the requirements for medical device risk management in China and European Union, this article finds the differences between them and provides reference for technical review.

Key words: font-size:medium, ">Medical device; Registration; Risk management

中图分类号: